Why This Matters
Biocompatibility and sterilization are not isolated checkpoints. They influence:
- Material selection
- Manufacturing process decisions
- Device performance and durability
- Validation and documentation
Understanding these interactions early helps teams move forward with greater confidence.
Key Considerations
When evaluating additive manufacturing for medical devices, teams should consider:
- Material compatibility with intended use and patient contact
- Impact of sterilization methods on material properties
- Surface characteristics and post-processing implications
- Traceability and documentation requirements
These factors often evolve alongside device maturity.
Common Pitfalls
- Evaluating biocompatibility too late in development
- Assuming sterilization compatibility without validation
- Overlooking how surface finish affects cleanability
- Changing materials late and triggering re-validation
- Early alignment reduces downstream surprises.
Where This Fits in the Device Lifecycle
- During design and material selection
- Before validation and verification testing
- When preparing for pilot or early production
These considerations support smoother transitions toward commercialization.
Why Stratasys Direct
- Experience supporting medical device programs across development and production
- ISO 13485–certified quality system
- Broad additive manufacturing materials and processes
Want a concise reference? View the Biocompatibility & Sterilization Quick Guide
